What is the target hemoglobin (Hb) level during pregnancy?

Target Hemoglobin in Pregnancy

The target hemoglobin during pregnancy varies by trimester: ≥11.0 g/dL in the first trimester, ≥10.5 g/dL in the second trimester, and ≥11.0 g/dL in the third trimester, with anemia defined below these thresholds. 1

Trimester-Specific Hemoglobin Thresholds

The CDC guidelines establish clear cutoff values for defining anemia at different stages of pregnancy 1:

• First trimester (12 weeks): Hb <11.0 g/dL indicates anemia
• Second trimester (16-28 weeks): Hb <10.5-10.6 g/dL indicates anemia
• Third trimester (32-40 weeks): Hb <11.0-11.9 g/dL indicates anemia (gradually increasing toward term)

These thresholds account for the physiologic hemodilution that occurs during pregnancy, where plasma volume expands disproportionately to red blood cell mass, causing hemoglobin to naturally decline in the first and second trimesters before rising again in the third trimester among iron-replete women 1, 2.

Critical Clinical Thresholds

Severe anemia requiring immediate specialist referral occurs when Hb <9.0 g/dL or hematocrit <27.0% 1. This level demands evaluation by a physician experienced in managing anemia during pregnancy, as it poses significant risks to both mother and fetus.

Conversely, excessively high hemoglobin (>15.0 g/dL or hematocrit >45.0%) during the second or third trimester is also concerning 1. This suggests inadequate blood volume expansion and associates with poor pregnancy outcomes including preterm delivery, fetal growth restriction, and fetal death 1.

Optimal Hemoglobin Range

Recent high-quality research reveals U-shaped relationships between hemoglobin and adverse outcomes, with optimal ranges of 10.5-12.5 g/dL during the second and third trimesters 3. Both low and high hemoglobin concentrations increase risks of gestational diabetes, preeclampsia, postpartum hemorrhage, preterm birth, small-for-gestational-age infants, and neonatal complications 3, 4.

Screening and Management Algorithm

Screen all pregnant women at the first prenatal visit and again at 24-28 weeks gestation 1:

1. If Hb is normal for gestational age: Continue routine 30 mg/day iron supplementation started at first prenatal visit 1

2. If anemia detected (below trimester-specific threshold):

   • Confirm with repeat hemoglobin or hematocrit
   • If Hb ≥9.0 g/dL: Treat presumptively as iron deficiency anemia with 60-120 mg/day oral iron 1
   • If Hb <9.0 g/dL: Refer to specialist immediately 1

3. Reassess after 4 weeks of treatment:

   • Expect Hb increase of ≥1 g/dL or hematocrit increase of ≥3%
   • If no response despite compliance: Evaluate with MCV, RDW, serum ferritin 1
   • Consider thalassemia minor or sickle cell trait in women of African, Mediterranean, or Southeast Asian ancestry 1

4. When Hb normalizes: Reduce iron dose to 30 mg/day maintenance 1

Important Caveats

The evidence shows that maintaining hemoglobin ≥11.0 g/L throughout pregnancy associates with optimal long-term child neurocognitive development 5. However, avoid over-correction—the goal is not to maximize hemoglobin but to maintain it within the physiologic range for each trimester. Excessively high hemoglobin indicates poor plasma volume expansion and predicts adverse outcomes 1, 2.

Race-specific considerations exist: Black women have hemoglobin distributions 0.5-0.9 g/dL lower than white women even without iron deficiency 1. While guidelines don't provide race-adjusted thresholds, clinicians should recognize this may affect screening accuracy.